Literature DB >> 178892

Viral glycoprotein synthesis studies in an established line of Japanese quail embryo cells infected with the Bryan high-titer strain of Rous sarcoma virus.

M S Halpern, D P Bolognesi, R R Friis.   

Abstract

Although a glycoprotein with an approximate molecular weight of 43,000 is associated with purified virions of the Bryan high-titer strain of Rous sarcoma virus propagated on R(-)Q cells, these virions lack gp85, the major glycoprotein of the avian tumor virus envelope. As measured by immune precipitation with a specific antiserum, gp85 does not accumulate to detectable levels in R(-)Q cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178892      PMCID: PMC515575     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  16 in total

1.  Absence of surface projections of some noninfectious forms of RSV.

Authors:  C de Giuli; S Kawai; S Dales; H Hanafusa
Journal:  Virology       Date:  1975-07       Impact factor: 3.616

2.  Further evidence for the existence of a viral envelope protein defect in the Bryan high-titer strain of Rous sarcoma virus.

Authors:  H Ogura; R Friis
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

3.  RNA of replication-defective strains of Rous sarcoma virus.

Authors:  P H Duesberg; S Kawai; L H Wang; P K Vogt; H M Murphy; H Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1975-04       Impact factor: 11.205

4.  A study of the relationship of reticuloendotheliosis virus to the avian leukosis-sarcoma complex of viruses.

Authors:  M S Halpern; E Wade; E Rucker; K L Baxter-Gabbard; A S Levine; R R Friis
Journal:  Virology       Date:  1973-06       Impact factor: 3.616

5.  Electrophoretic analysis of the RNA of avian tumor viruses.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

6.  Abortive infection of Japanese quail cells with avian sarcoma viruses.

Authors:  R R Friis
Journal:  Virology       Date:  1972-12       Impact factor: 3.616

7.  A cell-associated factor essential for formation of an infectious form of Rous sarcoma virus.

Authors:  H Hanafusa; T Miyamoto; T Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  1970-06       Impact factor: 11.205

8.  Proteins of helper-dependent RSV.

Authors:  C M Scheele; H Hanafusa
Journal:  Virology       Date:  1971-08       Impact factor: 3.616

9.  Proteins of Rous sarcoma virus.

Authors:  P H Duesberg; H L Robinson; W S Robinson; R J Huebner; H C Turner
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

10.  Group-specific antigenic determinants of the large envelope glycoprotein of avian oncornaviruses.

Authors:  L Rohrschneider; H Bauer; D P Bolognesi
Journal:  Virology       Date:  1975-09       Impact factor: 3.616

View more
  6 in total

1.  Analysis of precursors to the envelope glycoproteins of avian RNA tumor viruses in chicken and quail cells.

Authors:  K Moelling; M Hayami
Journal:  J Virol       Date:  1977-06       Impact factor: 5.103

2.  Polyethylene glycol-mediated infection with avian sarcoma viruses.

Authors:  W Rohde; G Pauli; J Henning; R R Friis
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

3.  Evidence for a Gp85-related glycoprotein in cells transformed by the Bryan high titer strain of Rous sarcoma virus.

Authors:  G Pauli; B Fleischer
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

4.  Envelope assembly mutant of rous sarcoma virus.

Authors:  K S Steimer; D Boettiger
Journal:  J Virol       Date:  1980-12       Impact factor: 5.103

5.  Transformation-associated cell surface antigens in virus and chemically transformed avian cells.

Authors:  H Bauer; J Ignjatovic; H Rübsamen; M Hayami
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

6.  Suppression of glycoprotein formation of Semliki Forest, influenza, and avian sarcoma virus by tunicamycin.

Authors:  R T Schwarz; J M Rohrschneider; M F Schmidt
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.